Return to Trial Database

BTCRC-LYM20-463

A Single Arm Phase I/II Study of Tazemetostat with Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma

Status

Currently Enrolling

Cancer Type(s)

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial BTCRC-LYM20-463 being conducted in.

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Rutgers Cancer Institute of New Jersey

The Ohio State University

University of Illinois Cancer Center

University of Wisconsin Carbone Cancer Center